QUANTIFERON®-TB Gold Plus Test
FDA premarket approval P010033/S048 · decided 2023-01-24
Approval details
- PMA number
- P010033
- Supplement
- S048
- Supplement type
- Real-Time Process
- Supplement reason
- Labeling Change - Indications/instructions/shelf life/tradename
- Trade name
- QUANTIFERON®-TB Gold Plus Test
- Generic name
- TEST, IMMUNITY, CELL MEDIATED, MYCOBACTERIUM TUBERCULOSIS
- Applicant
- Qiagen
- Date received
- 2022-09-30
- Decision date
- 2023-01-24
- Days to decision
- 116 days
- Decision code
- APPR
- Product code
- NCD
- Advisory committee
- Microbiology
- Expedited review
- No
- Location
- Germantown, MD
- Statement
- Approval of the addition of Sodium Heparin tubes as an alternative for blood collection in the workflow of the Quantiferon TB Gold Plus Test
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.
510(k) clearances by this applicant
| Record | Firm | Date |
|---|---|---|
| artus HSV-1/2 QS-RGQ MDx Kit (K142738) | Qiagen | 2014-12-19 |